Science Explorer Back to mapMap

Most cited papers from Teva Pharmaceuticals (Netherlands)

What are the most cited papers from Teva Pharmaceuticals (Netherlands)?

The most cited paper from Teva Pharmaceuticals (Netherlands) is "Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial" (Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al., 2019), with 445 citations. Next come "Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling" (354) and "Digital technologies and adherence in respiratory diseases: the road ahead" (144).

Showing 50 of 60 papers. Every paper with more than 11 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al. · The Lancet 16 Aug 2019 445
2 Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling Gerty Schreibelt, Gijs Kooij, Arie Reijerkerk et al. · The FASEB Journal 22 Jun 2007 354
3 Digital technologies and adherence in respiratory diseases: the road ahead John Blakey, Bruce G. Bender, Alexandra Lelia Dima et al. · European Respiratory Journal Open access Nov 2018 144
4 Digital Health Technology in Asthma: A Comprehensive Scoping Review Giselle S Mosnaim, GUILHERME G SAFIOTI, Randall W. Brown et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 27 Feb 2021 120
5 The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries Adam P Lewis, Saku Torvinen, P.N.R. Dekhuijzen et al. · BMC Health Services Research Open access 12 Jul 2016 102
6 Role of Editorial and Peer Review Processes in Publication Bias: Analysis of Drug Trials Submitted to Eight Medical Journals Marlies van Lent, John Overbeke, Henk Jan Out · PLoS ONE Open access 12 Aug 2014 81
7 Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma Lulu K. Lee, Karthik Ramakrishnan, GUILHERME G SAFIOTI et al. · BMJ Open Respiratory Research Open access Mar 2020 73
8 A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors Njira Lucia Lugogo, Michael R. DePietro, Michael Reich et al. · Journal of Asthma and Allergy Open access Nov 2022 65
9 Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study Richard B. Lipton, Joshua M. Cohen, Maja Galić et al. · Headache The Journal of Head and Face Pain Open access Apr 2021 60
10 Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions Giorgio Walter Canonica, Jan Arp, Johan René Keegstra et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 9 Sep 2015 54
11 The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients Josep Darbà, Gabriela A. Galan Ramirez, Pablo Francoli-Martínez et al. · International Journal of COPD Open access Oct 2015 53
12 Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler Henry Chrystyn, GUILHERME G SAFIOTI, Johan René Keegstra et al. · International Journal of Pharmaceutics Open access 4 Jun 2015 52
13 Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis J.S. Elborn, A.L. Vataire, Ayako Fukushima et al. · Clinical Therapeutics ReviewOpen access Oct 2016 50
14 Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1) Flavia Cecilia Lega Hoyte, Giselle S Mosnaim, Linda Joanne Rogers et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 28 Aug 2022 48
15 Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine Maurice T. Driessen, Joshua M. Cohen, Stephen F. Thompson et al. · The Journal of Headache and Pain Open access 16 May 2022 44
16 Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research James Mahon, Anita Fitzgerald, Julie Glanville et al. · Respiratory Medicine Open access 15 May 2017 44
17 Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study Messoud Ashina, Joshua M. Cohen, Maja Galić et al. · The Journal of Headache and Pain Open access 10 Jul 2021 43
18 Differences between information in registries and articles did not influence publication acceptance Marlies van Lent, Joanna IntHout, Henk Jan Out · Journal of Clinical Epidemiology Open access 30 Nov 2014 42
19 Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice Michael E. Wechsler, Stephen P. Peters, Tanisha D. Hill et al. · CHEST Journal Open access 16 Dec 2020 40
20 The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research Ratko Djukanović, Ian Michael Adcock, Gary P. Anderson et al. · European Respiratory Journal Open access Nov 2018 39
21 Increased Post-Thaw Viability and Phase I and II Biotransformation Activity in Cryopreserved Rat Liver Slices after Improvement of a Fast-Freezing Method Inge A.M. de Graaf, D. van der Voort, Johannes Hendrik Wilhelmus Machiel Brits et al. · Drug Metabolism and Disposition Sep 2000 38
22 Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States Peter McAllister, Lois E. Lamerato, Lynda J. Krasenbaum et al. · The Journal of Headache and Pain Open access Dec 2021 37
23 A review of the value of innovation in inhalers for COPD and asthma Johann Christian Virchow Jr., Cezmi A. Akdiş, Josep Darbà et al. · Journal of Market Access & Health Policy Open access 2015 37
24 Effectiveness of a Maintenance and Reliever Digihaler System in Asthma: 24-Week Randomized Study (CONNECT2) Giselle S Mosnaim, Flavia Cecilia Lega Hoyte, GUILHERME G SAFIOTI et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 30 Nov 2023 36
25 An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease Caitlin A. Jones, Louisa C. Johnston, Michael S. Jackson et al. · European Neuropsychopharmacology 3 May 2010 33
26 Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment Natalia Hawken, Saku Torvinen, Mohamed-Elmoctar Neine et al. · BMC Pulmonary Medicine Open access 6 Jul 2017 30
27 Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler) Niklas Sandler, Jenny Holländer, D Långström et al. · BMJ Open Respiratory Research Open access Mar 2016 30
28 Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study) Nicolás Roche, Vicente Plaza, Vibeke Backer et al. · npj Primary Care Respiratory Medicine Open access 7 Jan 2020 28
29 Cost-Effectiveness and Impact on Health Care Utilization of Interventions to Improve Medication Adherence and Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review Job F. M. van Boven, Federico Lavorini, Tamás Ágh et al. · The Journal of Allergy and Clinical Immunology In Practice ReviewOpen access 4 Jan 2024 25
30 A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir Vincent A. de Weger, Frederik E. Stuurman, Jeroen J. M. A. Hendrikx et al. · European Journal of Cancer Open access 12 Oct 2017 25
31 Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study Richard B. Lipton, Joshua M. Cohen, Kristen B. Bibeau et al. · Headache The Journal of Head and Face Pain Open access Nov 2020 24
32 A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States Lynda J. Krasenbaum, V. Pedarla, Stephen F. Thompson et al. · The Journal of Headache and Pain Open access 4 May 2022 23
33 Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study Maurice T. Driessen, Joshua M. Cohen, Oscar Patterson‐Lomba et al. · The Journal of Headache and Pain Open access 11 Apr 2022 22
34 A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir Vincent A. de Weger, Frederik E. Stuurman, Stijn L.W. Koolen et al. · Clinical Cancer Research Open access 19 Jun 2019 22
35 Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma Eric Donn Bateman, Ratko Djukanović, Mario Castro et al. · American Journal of Respiratory and Critical Care Medicine 22 Oct 2018 22
36 Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction Adrie P. De Jong, Aad J. Wittebrood, Wilma M. Du Chǎtinier et al. · Journal of Chromatography B Biomedical Sciences and Applications 1987 22
37 Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study Andrea Ines Ciplea, Anna Kurzeja, Sandra Thiel et al. · Multiple Sclerosis Journal Open access Apr 2022 20
38 Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance Josep Darbà, Gabriela A. Galan Ramirez, Laura García-Bujalance et al. · Patient Preference and Adherence Open access Feb 2016 20
39 Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review Marlies van Lent, Gerard A. P. J. M. Rongen, Henk Jan Out · BMC Medical Ethics Open access Dec 2014 20
40 Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study Messoud Ashina, Dimos Dimitrios Mitsikostas, Faisal Mohammad Amin et al. · Cephalalgia Open access Nov 2023 19
41 Transformation of Value in Innovative Business Models: The Case of Pharmaceutical Market Denis Klimanov, Olga Tretyak, Uri Goren et al. · Foresight-Russia Open access 24 Sep 2021 19
42 PEARL Study Protocol: a Real-World Study of Fremanezumab Effectiveness in Patients with Chronic or Episodic Migraine Messoud Ashina, Faisal Mohammad Amin, Pinar Kokturk et al. · Pain Management Open access 9 Jun 2021 19
43 Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Joshua M. Cohen et al. · The Journal of Headache and Pain Open access Dec 2021 18
44 Improved Sensitivity of Ultrasound‐Based Subharmonic Aided Pressure Estimation Using Monodisperse Microbubbles Wim van Hoeve, Miguel de Vargas Serrano, Lisa Te Winkel et al. · Journal of Ultrasound in Medicine Nov 2021 18
45 Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy Guy Brusselle, Janice Canvin, Sivan Weiss et al. · ERJ Open Research Open access Jul 2017 18
46 Oncofertility: insights from IVF specialists—a worldwide web-based survey analysis Gon Shoham, Rachel Levy-Toledano, Milton K. H. Leong et al. · Journal of Assisted Reproduction and Genetics Open access 20 Feb 2019 17
47 Costs in different states of prostate cancer Saku Torvinen, Niilo Färkkilä, Risto P. Roine et al. · Acta Oncologica Open access 2 Apr 2015 17
48 Recommendations for a uniform assessment of publication bias related to funding source Marlies van Lent, John Overbeke, Henk Jan Out · BMC Medical Research Methodology Open access 30 Sep 2013 17
49 Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study Marlies van Lent, Joanna IntHout, Henk Jan Out · BMJ Open Open access Sep 2015 15
50 Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours Marit A. C. Vermunt, Lisa T. van der Heijden, Jeroen J. M. A. Hendrikx et al. · Cancer Chemotherapy and Pharmacology 20 Mar 2021 14

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.